Evidence map›Paper›PMID 30894069›Full record

ArticleAutophagy2019

Impaired TFEB-mediated lysosomal biogenesis promotes the development of pancreatitis in mice and is associated with human pancreatitis.

Shaogui Wang, Hong-Min Ni, Xiaojuan Chao, Hua Wang, Brian Bridges, Sean Kumer, Timothy Schmitt, Olga Mareninova, Anna Gukovskaya, Robert C De Lisle and 3 more

Abstract read
In one paragraph

Article in Autophagy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 74 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
74citing papers in PubMed, 1 pooled it
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

74 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Review
  5. Crinophagy in Pancreatic Beta Cells: From Insulin Granule Turnover to Diabetes Pathogenesis.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review
  6. Review
  7. Article
  8. Acute pancreatitis: mechanisms and therapeutic approaches.Signal transduction and targeted therapy · 2026
    Review
  9. Article
  10. Article
  11. Targeted therapeutics for pancreatitis.Frontiers in physiology · 2026
    Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Association and functional study ofWorld journal of psychiatry · 2025
    Article

14 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Shaogui WangDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center , Kansas City , USA.
Hong-Min NiDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center , Kansas City , USA.
Xiaojuan ChaoDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center , Kansas City , USA.
Hua WangDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center , Kansas City , USA.
Brian BridgesLiver Center, University of Kansa Medical Center , Kansas City , USA.
Sean KumerDepartment of Surgery, University of Kansa Medical Center , Kansas City , USA.
Timothy SchmittDepartment of Surgery, University of Kansa Medical Center , Kansas City , USA.
Olga MareninovaDepartment of Medicine, David Geffen School of Medicine, University of California at Los Angeles , Los Angeles , CA , USA.
Anna GukovskayaDepartment of Medicine, David Geffen School of Medicine, University of California at Los Angeles , Los Angeles , CA , USA.
Robert C De LisleDepartment of Anatomy and Cell Biology, University of Kansas Medical Center , Kansas City , KS , USA.
Andrea BallabioTelethon Institute of Genetics and Medicine, TIGEM , Pozzuoli , Italy.ORCID 0000-0003-1381-4604
Pal PacherLaboratory of Cardiovascular Physiology and Tissue Injury, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health , Bethesda , MD , USA.
Wen-Xing DingDepartment of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center , Kansas City , USA.
University of Kansas Medical Center · USUniversity of California, Los Angeles · USAnhui Medical University · CNBaylor College of Medicine · USNational Institutes of Health · US

Funding

The Southernearch Center for ALPD and CirrhosisP50AA011999 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI HIDEKAZU TSUKAMOTO · 1999 to 2026
$45.8M
Mechanism of oxidative/nitrosative stress and inflammation-induced tissue injuryZIAAA000375 · NIAAA · NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM · PI PACHER, PAL · 2009 to 2025
$27.8M
Nuclear Receptors in Liver Health and DiseaseP20GM103549 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2012 to 2015
$8.1M
Vector and Human Acinar CoreP01DK098108 · NIDDK · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI GUKOVSKAYA, ANNA S. · 2014 to 2018
$8.1M
Pilot Grants ProgramP30GM118247 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI JAESCHKE, HARTMUT W. · 2016 to 2020
$5.5M
Autophagy and Drug-Induced Liver InjuryR01DK102142 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DING, WEN-XING, JAESCHKE, HARTMUT W. · 2014 to 2022
$2.7M
Mechanisms regulating autophagy in alcohol-induced liver injuryR01AA020518 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DING, WEN-XING · 2011 to 2018
$2.3M
Autophagy in Alcoholic PancreatitisU01AA024733 · NIAAA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI DING, WEN-XING · 2017 to 2021
$1.7M
Cell Death and Autophagy in Chronic PancreatitisI01BX004306 · VA · VA GREATER LOS ANGELES HEALTHCARE SYSTEM · PI GUKOVSKAYA, ANNA S. · 2018 to 2021
–
BLRD VA I01 BX004306NIAAA NIH HHS P50 AA011999NIAAA NIH HHS R01 AA020518NIAAA NIH HHS U01 AA024733NIDDK NIH HHS P01 DK098108NIDDK NIH HHS R01 DK102142NIGMS NIH HHS P20 GM103549NIGMS NIH HHS P30 GM118247
6 · The paper itself

Abstract

Impaired macroautophagy/autophagy has been implicated in experimental and human pancreatitis. However, the transcriptional control governing the autophagy-lysosomal process in pancreatitis is largely unknown. We investigated the role and mechanisms of TFEB (transcription factor EB), a master regulator of lysosomal biogenesis, in the pathogenesis of experimental pancreatitis. We analyzed autophagic flux, TFEB nuclear translocation, lysosomal biogenesis, inflammation and fibrosis in GFP-LC3 transgenic mice, acinar cell-specific

Indexed as

Acinar CellsAnimalsAutophagosomesAutophagyBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCell NucleusCeruletideDisease Models, AnimalHumansInflammationLysosomesMaleMiceMice, Inbred C57BLMice, TransgenicPancreasBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCeruletidemTOR protein, mouseProteasome Endopeptidase ComplexTcfe3 protein, mouseTcfeb protein, mouseTOR Serine-Threonine KinasesAutophagyceruleinexperimental pancreatitislysosometranscription factor

Identifiers

PMID30894069
PMCPMC6844531
OpenAlexW2924629237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.